Poseida Therapeutics Inc (PSTX) Company Profile & Statistics

Poseida Therapeutics Inc
PSTX
(Nasdaq - US)
N/A
3.20
-0.14 (-4.33%)
in:usd•As of: May 17, 2024 15:59 UTC -4
Open
3.27
High
3.31
Low
3.13

About Poseida Therapeutics Inc

CEO

Kristin Yarema

Headquarters

9390 towne centre drive, suite 200

san diego, ca 92121, united states

Auditor

Ernst & Young LLP

Employees

330

Share Holders

N/A

Website

www.poseida.com

Industry

biotechnology

Sector

health technology

Company Overview

Poseida Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing therapeutics for high unmet medical needs. The company is developing a pipeline of solutions for the treatment of hematological malignancies and solid tumors, as well as vivo programs for liver-directed gene therapies for rare diseases. In addition, it offers CAR-T therapies for the treatment for cancer. Poseida Therapeutics Inc. is based in San Diego, California.

Poseida Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	310.27M
Enterprise Value	315.67M
Enterprise Value/EBITDA (ttm)	-2.72
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.66
Price to Sales (ttm)	3.75
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-131.95%
Profit Margin (ttm)	-166.17%
Return on Equity (ttm)	-97.36%
Return on Invested Capital (ttm)	-64.18%
Return on Assets (ttm)	-38.88%

Income Statement

Revenue (ttm)	82.50M
Revenue Per Share (ttm)	0.85
Gross Profit (ttm)	82.50M
EBITDA (ttm)³	-116.13M
Net Income Avi to Common (ttm)	-108.86M
Diluted EPS (ttm)	-1.19

Share Statistics

Beta (5Y Monthly)	0.46
52-Week Change	24.03%
S&P500 52-Week Change	26.51%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	96.96M
Dividend Yield	0.00%
Float ⁴	94.92M
% Held by Insiders	2.10%
% Held by Institutions	46.87%

Balance Sheet

Total Cash (mrq)	198.65M
Total Cash Per Share (mrq)	2.05
Total Debt (mrq)	58.69M
Total Debt/Equity (mrq)	69.38%
Current Ratio (mrq)	2.56%
Quick Ratio (mrq)	3.18%
Book Value Per Share (mrq)	0.87

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.16
Free Cash Flow (ytd)	-15.27M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Poseida Therapeutics Inc

Trade With A Regulated Broker